BAVISANT
(4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone
Molecular Identity
BAVISANT
(4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone
PubChem CID: 16061509
2D Structure
Properties
C19H27N3O2
Molecular Formula
329.40
Molecular Weight
g/mol
329.2103
Exact Mass
Da
1.2
XLogP
Drug-like (Lipinski: < 5)
36
TPSA
Good oral absorption (< 140 A²)
0
H-Bond Donors
4
H-Bond Acceptors
418
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
BAVISANT929622-08-2JNJ-310010749827P7LFVHDTXSID001026045(4-Cyclopropylpiperazin-1-yl)(4-(morpholin-4-ylmethyl)phenyl)methanonebavisantum(4-Cyclopropylpiperazin-1-yl)[4-(morpholin-4-ylmethyl)phenyl]methanoneRefChem:916750DTXCID702079434-((4-(4-cyclopropylpiperazine-1-carbonyl)phenyl)methyl)morpholineUNII-9827P7LFVHBavisant [USAN:INN](4-cyclopropylpiperazin-1-yl)(4-(morpholinomethyl)phenyl)methanone929622-08-2(free base)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to BAVISANT
Loading drug network...